San Diego- and Boston-based Rapport Therapeutics has raised $150M in a Series B funding round, the company said this morning. According to the company, the funding was led by Cormorant Asset Management,
San Diego- and Boston-based Rapport Therapeutics announced this morning that it has raised $100M in a Series A funding round, to go towards its precision medicines for neurological disorders. The funding